arginyl-glycyl-aspartic acid has been researched along with 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YS; Cheon, GJ; Chung, JK; Hong, MK; Jeong, JM; Kim, YJ; Lee, DS; Lee, MC; Lee, YS | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid
Article | Year |
---|---|
Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
Topics: Animals; Coordination Complexes; Feasibility Studies; Gallium Radioisotopes; Heterocyclic Compounds; Hindlimb; Humans; Hypoxia; Ischemia; Isothiocyanates; Male; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Staining and Labeling; Transplantation, Heterologous | 2008 |